Press Releases
TxCell to present an innovative, personalized cell-based immunotherapy approach at the 16th BIO CEO & Investor Conference 2014, New York, USA
TxCell SA, a clinical stage biotechnology company developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, announces...
Research Insight
Body kills ‘spontaneous’ blood cancers on a daily basis
Immune cells undergo 'spontaneous' changes on a daily basis that could lead to cancers if not for the diligent surveillance of our immune system,...
News
Health ministry turns down SLAs’ demand for amending D&C Rules to define role of SLAs in monitoring clinical trials
3rd February 2014, India - The Union health ministry of India has turned down some of the state drug controllers' demand for an amendment...
News
Cancer Aid Society urges govt to relax norms on oral morphine to provide relief to cancer patients
The Cancer Aid Society of India has urged the government to relax norms with respect to availability and accessibility of oral morphine in the...
News
Roche NimbleGen Introduces Novel NGS Target Enrichment Solution for Methylation Assessment
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the launch of the SeqCap Epi Target Enrichment System for DNA methylation assessment at single-base resolution. This...
Press Releases
DARA BioSciences enters into pharmacy supply deal with RainTree
US-based pharmaceutical firm dedicated to the commercialization of oncology treatment and oncology supportive care products DARA BioSciences has signed a pharmacy...
Research Insight
Oramed releases Phase IIa trial of ORMD-0801 to treat type 2 diabetes
Oramed Pharmaceuticals has released results of a Phase IIa clinical trial of its ORMD-0801, an oral insulin capsule for the treatment...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read